Address
MPM Capital
601 Gateway Boulevard
Suite 350
South San Francisco, CA 94080
United States
Phone
Email
Website
Recent investment activity
KANDO id: 30789
Relation
Renamed to
Funds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| MPM BioVentures IV | 2007 | USD | 550,000,000 | |
| MPM BioVentures III | 2002 | USD | 949,000,000 | |
| MPM BioVentures II | 2000 | USD | 600,000,000 | |
| MPM BioVentures I | 1997 | USD | 230,000,000 |
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 71| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Allos Therapeutics Inc | N/A | ||||
|
|
Archus Orthopedics Inc | Spinal and orthopedic implant and instrument company. | Series C | |||
|
Arena Pharmaceuticals Inc | N/A | ||||
|
|
Astute Medical Inc | Dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers | Series C | |||
|
|
Caliper Life Sciences Inc | N/A | ||||
|
|
Cardiac Dimensions Inc | Medical device company developing novel interventional tools for the treatment of heart failure & the related condition of mitral valve regurgitation. | N/A | |||
|
|
Celladon Corp | N/A | ||||
|
|
Cellerant Therapeutics Inc | Biotechnology company with a portfolio of products based on the regulation of the hematopoietic (blood-forming) system. | N/A | |||
|
|
Ceregene Inc | Biotechnology company focused on the development and commercialization of gene therapies for the treatment of neurological disorders. | Series D | |||
|
|
Cerimon Pharmaceuticals Inc | Biopharmaceutical company dedicated to bringing innovative therapeutics to patients with substantial, unmet medical needs. | N/A | |||
|
|
CGI Pharmaceuticals Inc | A biopharmaceutical company developing small molecule therapeutics for multiple oncology and immunology-based indications. | N/A | |||
|
|
Coelacanth Chemical Corp | N/A | ||||
|
|
CoTherix Inc | N/A | ||||
|
|
Critical Therapeutics Inc | Discoverer, developer and commercialize novel therapies. | N/A | |||
|
|
CryoCor Inc | N/A | ||||
|
|
EnteroMedics Inc | Develops therapeutic devices for the treatment of obesity. Its VSM technology uses electrical signals, delivered by an implantable electrode array, to | N/A | |||
|
|
Eyetech Pharmaceuticals Inc | Biopharmaceutical company that specializes in the development and commercialization of novel therapeutics to treat diseases of the eye. | N/A | |||
|
|
ForteBio Inc | N/A | ||||
|
|
Helicos BioSciences Corp | A pioneer in high-speed, high-sensitivity DNA sequencing. | N/A | |||
|
|
IDUN Pharmaceuticals Inc | N/A | ||||
|
|
Innovative Spinal Technologies Inc | Spine technology company. | Series C | |||
|
|
Memory Pharmaceuticals Corp | N/A | ||||
|
|
Metabasis Therapeutics Inc | Biopharmaceutical company focused on the discovery, development & commercialization of novel small molecule therapies drugs for diseases of the liver. | N/A | |||
|
|
Metabolex Inc | Focuses on the discovery and development of novel therapeutics for the treatment of diabetes. | Series D | |||
|
|
NeuroTherapeutics Pharma Inc | N/A |